Cargando…

Fibroblast‐growth‐factor‐23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes

AIMS: This study aimed to assess plasma fibroblast growth factor 23 (FGF23) in patients with heart failure with preserved ejection fraction (HFpEF) and its relation to inflammation, renal function, clinical and imaging characteristics, exercise capacity, and prognosis. METHODS AND RESULTS: We perfor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanagala, Prathap, Arnold, Jayanth R., Khan, Jamal N., Singh, Anvesha, Gulsin, Gaurav S., Eltayeb, Mohamed, Gupta, Pankaj, Squire, Iain B., McCann, Gerry P., Ng, Leong L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755022/ https://www.ncbi.nlm.nih.gov/pubmed/32935918 http://dx.doi.org/10.1002/ehf2.13020

Ejemplares similares

Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2020)

Plasma P‐selectin is a predictor of mortality in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2021)

Intra-study and inter-technique validation of cardiovascular magnetic resonance imaging derived left atrial ejection fraction as a prognostic biomarker in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2020)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach
por: Kanagala, Prathap, et al.
Publicado: (2020)

Novel plasma and imaging biomarkers in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2015)

Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction – implications for clinical trials
por: Kanagala, Prathap, et al.
Publicado: (2018)

Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes
por: Gulsin, Gaurav S., et al.
Publicado: (2019)

Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis
por: Bilak, Joanna M, et al.
Publicado: (2022)

The many faces of HFPEF: insights from the CMR substudy of DIAMOND-HFPEF
por: Kanagala, Prathap, et al.
Publicado: (2015)

Latest British Society of Echocardiography recommendations for left ventricular ejection fraction categorisation: potential implications and relevance to contemporary heart failure management
por: Kanagala, Prathap, et al.
Publicado: (2020)

Multi-modality assessment and role of left atrial function as an imaging biomarker in cardiovascular disease
por: Alfuhied, Aseel, et al.
Publicado: (2021)

The role of cardiac magnetic resonance imaging in the assessment of heart failure with preserved ejection fraction
por: Lau, Clement, et al.
Publicado: (2022)

Reproducibility of left atrial function using cardiac magnetic resonance imaging
por: Alfuhied, Aseel, et al.
Publicado: (2020)

Proenkephalin and prognosis in heart failure with preserved ejection fraction: a GREAT network study
por: Kanagala, Prathap, et al.
Publicado: (2019)

Inter-study reproducibility of circumferential strain and strain rates at 1.5T and 3T: a comparison of tagging and feature tracking
por: Singh, Anvesha, et al.
Publicado: (2014)

Inter-study repeatability of circumferential strain and diastolic strain rate by CMR tagging, feature tracking and tissue tracking in ST-segment elevation myocardial infarction
por: Nazir, Sheraz A., et al.
Publicado: (2020)

Comparison of cardiovascular magnetic resonance feature tracking and tagging for the assessment of left ventricular systolic strain in acute myocardial infarction
por: Khan, Jamal N, et al.
Publicado: (2015)

Comparison of T1-mapping and T2-weighted imaging for diagnostic oedema assessment in ST-segment elevation myocardial infarction
por: Nazir, Sheraz A, et al.
Publicado: (2016)

Effect of late sodium current inhibition on MRI measured diastolic dysfunction and myocardial perfusion reserve in aortic stenosis: a pilot study
por: Singh, Anvesha, et al.
Publicado: (2015)

Correction to: does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
por: Gulsin, Gaurav S., et al.
Publicado: (2019)

Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
por: Gulsin, Gaurav S., et al.
Publicado: (2017)

Comparison of semi-automated methods to quantify infarct size and area at risk by cardiovascular magnetic resonance imaging at 1.5T and 3.0T field strengths
por: Khan, Jamal N, et al.
Publicado: (2015)

Prevalence and extent of infarct and microvascular obstruction following a range of reperfusion techniques in ST-elevation myocardial infarction
por: Khan, Jamal N, et al.
Publicado: (2013)

Diabetic cardiomyopathy: prevalence, determinants and potential treatments
por: Gulsin, Gaurav S., et al.
Publicado: (2019)

Gross right heart dilatation secondary to Ebstein's anomaly
por: Gulsin, Gaurav Singh, et al.
Publicado: (2016)

Cardiovascular and systemic determinants of exercise capacity in people with type 2 diabetes mellitus
por: Bilak, Joanna M., et al.
Publicado: (2021)

Fibroblast Growth Factor‐23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA
por: Almahmoud, Mohamed Faher, et al.
Publicado: (2018)

Prevalence and extent of infarct and microvascular obstruction following different reperfusion therapies in ST-elevation myocardial infarction
por: Khan, Jamal N, et al.
Publicado: (2014)

MECHANISMS IN ENDOCRINOLOGY: Diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review
por: Levelt, Eylem, et al.
Publicado: (2018)

Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction
por: Roy, Clotilde, et al.
Publicado: (2020)

Larger infarct size associated with dysglycemia at the time of ST-elevation myocardial infarction is related to later presentation
por: Razvi, Naveed, et al.
Publicado: (2013)

Short-term adverse remodeling progression in asymptomatic aortic stenosis
por: Singh, Anvesha, et al.
Publicado: (2020)

Sex and ethnic differences in the cardiovascular complications of type 2 diabetes
por: Yeo, Jian L., et al.
Publicado: (2021)

Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study
por: Binnenmars, S. Heleen, et al.
Publicado: (2022)

Fibro‐inflammatory recovery and type 2 diabetes remission following a low calorie diet but not exercise training: A secondary analysis of the DIASTOLIC randomised controlled trial
por: Brady, Emer M., et al.
Publicado: (2022)

Effects of late, repetitive remote ischaemic conditioning on myocardial strain in patients with acute myocardial infarction
por: Arnold, J. Ranjit, et al.
Publicado: (2022)

Effect of late sodium current inhibition on MRI measured diastolic dysfunction in aortic stenosis: a pilot study
por: Singh, Anvesha, et al.
Publicado: (2016)

The impact of lifestyle intervention on left atrial function in type 2 diabetes: results from the DIASTOLIC study
por: Alfuhied, Aseel, et al.
Publicado: (2022)

The assessment of coronary artery disease in patients with end-stage renal disease
por: Poli, Federica E, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gt9pfbklnht4kdkk6j5kssd9de